Clinical Trial Update: Diagnosis and Staging of Neuroendocrine Tumors (NETs) Utilizing 68Ga-DOTATOC PET/CT Scan [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the use of 68Ga-DOTATOC PET/CT for diagnosis and staging of neuroendocrine tumors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Snippet

Sponsor: Montefiore Medical Center | Conditions: Neuroendocrine Tumors | Phase 3 | Status: COMPLETED | Results posted: 2019-01-30